Preferences for long‐acting pre‐exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey

INTRODUCTION: While various antiretrovirals have been studied as potential candidates for long‐acting pre‐exposure prophylaxis (PrEP), the bimonthly injectable cabotegravir—the first long‐acting form of PrEP—was approved in 2021. Event‐driven (ED) PrEP has been the most prevalent dosing regimen amon...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Jing‐Hao, Ku, Stephane Wen‐Wei, Chen, Tsai‐Wei, Li, Chia‐Wen, Huang, Poyao, Wu, Huei‐Jiuan, Bourne, Adam, Strong, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483501/
https://www.ncbi.nlm.nih.gov/pubmed/37675767
http://dx.doi.org/10.1002/jia2.26163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483501/
https://www.ncbi.nlm.nih.gov/pubmed/37675767
http://dx.doi.org/10.1002/jia2.26163

Ejemplares similares